Predicting Synthetic Lethal Interactions using Heterogeneous Data Sources.
暂无分享,去创建一个
[1] Shan Zhao,et al. Mining protein networks for synthetic genetic interactions , 2008, BMC Bioinformatics.
[2] Ricard V. Solé,et al. Human synthetic lethal inference as potential anti-cancer target gene detection , 2009, BMC Systems Biology.
[3] Kevin R Brown,et al. Essential gene profiles in breast, pancreatic, and ovarian cancer cells. , 2012, Cancer discovery.
[4] Christian M. Metallo,et al. Combinatorial CRISPR-Cas9 Metabolic Screens Reveal Critical Redox Control Points Dependent on the KEAP1-NRF2 Regulatory Axis. , 2018, Molecular cell.
[5] Mark D. M. Leiserson,et al. Precision Oncology: The Road Ahead. , 2017, Trends in molecular medicine.
[6] Wolfgang Huber,et al. Mapping genetic interactions in human cancer cells with RNAi and multiparametric phenotyping , 2013, Nature Methods.
[7] Hui Liu,et al. SynLethDB: synthetic lethality database toward discovery of selective and sensitive anticancer drug targets , 2015, Nucleic Acids Res..
[8] Martin H. Schaefer,et al. HIPPIE v2.0: enhancing meaningfulness and reliability of protein–protein interaction networks , 2016, Nucleic Acids Res..
[9] Gary D Bader,et al. International network of cancer genome projects , 2010, Nature.
[10] Subarna Sinha,et al. Systematic discovery of mutation-specific synthetic lethals by mining pan-cancer human primary tumor data , 2017, Nature Communications.
[11] Eytan Ruppin,et al. Predicting Cancer-Specific Vulnerability via Data-Driven Detection of Synthetic Lethality , 2014, Cell.
[12] A. Tutt,et al. Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial , 2010, The Lancet.
[13] J. Martens,et al. A novel independence test for somatic alterations in cancer shows that biology drives mutual exclusivity but chance explains most co-occurrence , 2016, bioRxiv.
[14] Sue Povey,et al. The HGNC Database in 2008: a resource for the human genome , 2007, Nucleic Acids Res..
[15] Eyal Gottlieb,et al. Inborn and acquired metabolic defects in cancer , 2011, Journal of Molecular Medicine.
[16] M. Zelen,et al. Rethinking centrality: Methods and examples☆ , 1989 .
[17] Vaibhav Rajan,et al. Deep collective matrix factorization for augmented multi-view learning , 2018, Machine Learning.
[18] Davide Heller,et al. STRING v10: protein–protein interaction networks, integrated over the tree of life , 2014, Nucleic Acids Res..
[19] A. Tutt,et al. Phase II trial of the oral PARP inhibitor olaparib in BRCA-deficient advanced breast cancer. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[20] Samuel Schmidt,et al. The political network in Mexico , 1996 .
[21] Martijn A. Huynen,et al. Genome evolution predicts genetic interactions in protein complexes and reveals cancer drug targets , 2013, Nature Communications.
[22] Nagarajan Natarajan,et al. Inductive matrix completion for predicting gene–disease associations , 2014, Bioinform..
[23] P. Bonacich. Factoring and weighting approaches to status scores and clique identification , 1972 .
[24] M. Friedman. A Comparison of Alternative Tests of Significance for the Problem of $m$ Rankings , 1940 .
[25] Thomas Helleday,et al. Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase , 2005, Nature.
[26] Trey Ideker,et al. A Network of Conserved Synthetic Lethal Interactions for Exploration of Precision Cancer Therapy. , 2016, Molecular cell.
[27] Bonnie Berger,et al. Compact Integration of Multi-Network Topology for Functional Analysis of Genes. , 2016, Cell systems.
[28] L. Freeman,et al. Centrality in valued graphs: A measure of betweenness based on network flow , 1991 .
[29] Leonard M. Freeman,et al. A set of measures of centrality based upon betweenness , 1977 .
[30] Xiangrong Chen,et al. Predicting synthetic lethal interactions using conserved patterns in protein interaction networks , 2019, PLoS Comput. Biol..
[31] Fan Zhang,et al. In Silico Prediction of Synthetic Lethality by Meta-Analysis of Genetic Interactions, Functions, and Pathways in Yeast and Human Cancer , 2014, Cancer informatics.
[32] Joshua M. Stuart,et al. The Cancer Genome Atlas Pan-Cancer analysis project , 2013, Nature Genetics.
[33] Steven J. M. Jones,et al. Comprehensive molecular portraits of human breast tumors , 2012, Nature.
[34] Fei Ji,et al. PhyloGene server for identification and visualization of co-evolving proteins using normalized phylogenetic profiles , 2015, Nucleic Acids Res..
[35] Gabriela Alexe,et al. Characterizing genomic alterations in cancer by complementary functional associations , 2016, Nature Biotechnology.
[36] Niko Beerenwinkel,et al. TiMEx: a waiting time model for mutually exclusive cancer alterations , 2015, Bioinform..
[37] Gaurav Pandey,et al. Prediction of Genetic Interactions Using Machine Learning and Network Properties , 2015, Front. Bioeng. Biotechnol..
[38] Benjamin E. Gross,et al. Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal , 2013, Science Signaling.
[39] Vipin Kumar,et al. An Integrative Multi-Network and Multi-Classifier Approach to Predict Genetic Interactions , 2010, PLoS Comput. Biol..
[40] Eytan Ruppin,et al. Harnessing synthetic lethality to predict the response to cancer treatment , 2018, Nature Communications.
[41] D. Hanahan,et al. Hallmarks of Cancer: The Next Generation , 2011, Cell.
[42] Aaron N. Chang,et al. Combinatorial CRISPR-Cas9 screens for de novo mapping of genetic interactions , 2017, Nature Methods.
[43] Hans-Werner Mewes,et al. CORUM: the comprehensive resource of mammalian protein complexes , 2007, Nucleic Acids Res..
[44] Martijn A. Huynen,et al. Predicting Human Genetic Interactions from Cancer Genome Evolution , 2015, PloS one.
[45] Roland Arnold,et al. A negative genetic interaction map in isogenic cancer cell lines reveals cancer cell vulnerabilities , 2013, Molecular systems biology.
[46] Pablo Tamayo,et al. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[47] P. Hieter,et al. Synthetic lethality and cancer , 2017, Nature Reviews Genetics.
[48] B. Taylor,et al. Implementing Genome-Driven Oncology , 2017, Cell.
[49] Gary D Bader,et al. The Genetic Landscape of a Cell , 2010, Science.